In Silico, In Vitro, and In Vivo Antinociceptive Potential of S ‐Naproxen Derivatives
ChemistryOpen · 2026-04 · 15 (4)
DOI: 10.1002/open.202500493 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 27.03.2026. Verfasst von Ubaidullah und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Swabi, Swabi, Khyber Pakhtunkhwa, Pakistan. Hauptthemen laut MEDLINE: Naproxen, Analgesics, Cyclooxygenase Inhibitors. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pakistan Academy of Science, Pakistan Academy of Sciences.
Abstract (Originalsprache)
Selected naproxen derivatives were investigated for their antinociceptive effects, using in vitro (COX‐I/COX‐II antagonistic effect), in vivo (acetic acid and hot plate assay), and in silico (molecular simulation studies) approaches. The COX inhibition studies revealed that the maximum percent effect exhibited by GMO‐I‐111a 96.01 and 92% against COX‐2 and COX‐1, respectively, at higher concentrations. The effect at minimum concentration was 81 and 77% against COX‐1 and COX‐2, respectively. The COX antagonist effect of GMO‐I‐9a and GMO‐I‐11a was also outstanding in the acetic acid assay. All the tested derivatives demonstrated a significant ( p < 0.05) analgesic effect at all concentrations (1.25, 2.5, and 10 mg/kg). The maximum effect was found against GMO‐I‐135a (95%), followed by GMO‐I‐11a (92%). The central analgesic effect of various derivatives was significant ( p < 00.1). GMO‐I‐111a exhibited a significant ( p < 00.1) analgesic effect after 30 min at all the tested doses. The maximum effect at higher doses was shown by compound GMO‐I‐9a (93%) followed by GMO‐I‐11a (88%), GMO‐I‐111a (84%), and GMO‐I‐135a (78%). The latency time of GMO‐I‐9a and GMO‐I‐135a was significantly reversed by naloxone treatment, indicating the central analgesic effect. The molecular simulation studies showed that all the tested compounds had good binding interactions with COX‐1/COX‐2, except GMO‐I‐9a . In conclusion, the tested naproxen derivatives might have a significant analgesic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Swabi, Swabi, Khyber Pakhtunkhwa, Pakistan.
- Department of Pharmacy, Abdul Wali Khan University, Mardan, Khyber Pakhtunkhwa, Pakistan.
- College of Engineering, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
- Research Institute for Sustainable Futures, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
- Department of Chemistry, University of Swabi, Anbar, Khyber Pakhtunkhwa, Pakistan.
- Deparment of Pharmacy, COMSAT University Abbottabad, Abbottabad, Pakistan.
ORCID-Profile: Abdur Rauf, Khalid Mohammed Khan, Marcello Iriti
Förderung
- Pakistan Academy of Science
- Pakistan Academy of Sciences
Zitieren
APA
Ubaidullah, Muhammad, N., Khan, A., Ajaj, R., Rauf, A., Rashid, U., Hussain, F., Khan, R., Seraj, F., Uzma, U., Ali, B., Sadiq, A., Khan, K. M., & Iriti, M. (2026). In Silico, In Vitro, and In Vivo Antinociceptive Potential of S ‐Naproxen Derivatives. ChemistryOpen, 15(4). https://doi.org/10.1002/open.202500493
Vancouver
Ubaidullah, Muhammad N, Khan A, Ajaj R, Rauf A, Rashid U, et al. In Silico, In Vitro, and In Vivo Antinociceptive Potential of S ‐Naproxen Derivatives. ChemistryOpen. 2026;15(4). doi:10.1002/open.202500493
BibTeX
@article{Ubaidullah2026,
author = {Ubaidullah and Muhammad, Naveed and Khan, Abad and Ajaj, Rahaf and Rauf, Abdur and Rashid, Umer and Hussain, Fahad and Khan, Rashid and Seraj, Faiza and Uzma, Uzma and Ali, Basharat and Sadiq, Abdul and Khan, Khalid Mohammed and Iriti, Marcello},
title = {In Silico, In Vitro, and In Vivo Antinociceptive Potential of S ‐Naproxen Derivatives},
journal = {ChemistryOpen},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/open.202500493}
}
EUVIMED